Perspectives

Episode #21: Embedding environmental sustainability into pharma’s DNA

Life Sciences Connect

Let’s make this work.

Change your targeting/advertising cookie settings to access this feature.

On this episode of Life Sciences Connect podcast, we bring the discussion of emission reduction to the forefront. Hear our guest discuss further:

James Gregson – UK’s Life Sciences & Healthcare industry leader

At the start of October we launched our report: Embedding environmental sustainability into pharma’s DNA. In this episode, we explore the pressing challenges facing pharma in achieving ambitious environmental sustainability targets and evaluate ways of making progress through easy wins across the value chain, culture changes and new investment.

These quick wins can provide the license to make transformative, fundamental changes that are necessary to achieve pharma’s targets.

Listen to hear more on this topic.

The Future of Diagnostics Reports

Read more

Speakers

Karen Taylor
Research Director, Centre for Health Solutions

Karen is the Research Director of the Centre for Health Solutions. She supports the Healthcare and Life Sciences practice by driving independent and objective business research and analysis into key industry challenges and associated solutions; generating evidence based insights and points of view on issues from pharmaceuticals and technology innovation to healthcare management and reform.

Read more

James Gregson
Partner

James has many years’ experience of working with some of the largest global pharmaceutical businesses, driving and leading cross-disciplinary teams from multiple geographies and businesses.

Read more

Find out more

If you are interested in any of the topics discussed during this episode and want more information, please explore some useful links below:

Life Sciences Connect

To see the full collections of episodes so far, please visit the Life Sciences Connect podcast library.

 

Fullwidth SCC. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Did you find this useful?
Life Sciences Connect

Our podcast series on the Life Sciences and Healthcare Industries

Embedding environmental sustainability into pharma's DNA | Deloitte UK

The pharmaceutical industry’s involvement in environmental issues is multifaceted, with implications for the entire product value chain. From research and development (R&D) and supply chain (procurement, manufacturing, transportation, logistics and other services), to patient engagement, modes of delivery and the disposal of products, all aspects of the process are affected.